+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 4751754
The global biomaterials market size is expected to reach USD 488.71 billion by 2030, registering a CAGR of 15.52% over the forecast period. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes’ extracellular matrix, thus replacing the traditional organ transplantation procedures.

Biomaterials Market Report Highlights

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
  • North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient's portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Biomaterials Market

What is the estimated value of the Global Biomaterials Market?

The Global Biomaterials Market was estimated to be valued at $155.05 Billion in 2022.

What is the growth rate of the Global Biomaterials Market?

The growth rate of the Global Biomaterials Market is 15.5%, with an estimated value of $488.71 Billion by 2030.

What is the forecasted size of the Global Biomaterials Market?

The Global Biomaterials Market is estimated to be worth $488.71 Billion by 2030.

Who are the key companies in the Global Biomaterials Market?

Key companies in the Global Biomaterials Market include Medtronic, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings, Inc., BASF SE, Covalon Technologies Ltd., Stryker and Johnson & Johnson.

Table of Contents

Chapter 1 Research Methodology & Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2 Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3 Biomaterials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Demand As A Consequence Of Accidental Injuries & Chronic Conditions
3.2.1.2. Advances In Biomaterials Technologies
3.2.1.3. Expansion In The Usage Scope Of Biomaterials
3.2.2. Market Restraint Analysis
3.2.2.1. High Expense Associated With The Development Of Biomaterials
3.2.2.2. Problems Related To Biocompatibility Of Biomaterials
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4 Biomaterials Market: Product Business Analysis
4.1 Biomaterials Market: Product Movement Analysis
4.2 Metallic
4.2.1 Metallic Biomaterials Market, 2018 - 2030 (USD Billion)
4.3 Natural
4.3.1 Natural Biomaterials Market, 2018 - 2030 (USD Billion)
4.4 Ceramics
4.4.1 Ceramics Biomaterials Market, 2018 - 2030 (USD Billion)
4.5 Polymers
4.5.1 Polymers Biomaterials Market, 2018 - 2030 (USD Billion)
Chapter 5 Biomaterials Market: Application Business Analysis
5.1 Biomaterials Market: Application Movement Analysis
5.2 Cardiovascular
5.2.1 Cardiovascular Market, 2018 - 2030 (USD Billion)
5.2.2 Sensors
5.2.2.1 Sensors Market, 2018 - 2030 (USD Billion)
5.2.3 Stents
5.2.3.1 Stents Market, 2018 - 2030 (USD Billion)
5.2.4 Guidewires
5.2.4.1 Guidewires Market, 2018 - 2030 (USD Billion)
5.2.5 Implantable Cardiac Defibrillators
5.2.5.1 Implantable Cardiac Defibrillators Market, 2018 - 2030 (USD Billion)
5.2.6 Pacemakers
5.2.6.1 Pacemakers Market, 2018 - 2030 (USD Billion)
5.2.7 Vascular Grafts
5.2.7.1 Vascular Grafts Market, 2018 - 2030 (USD Billion)
5.2.8 Others
5.2.8.1 Other Cardiovascular Applications Market, 2018 - 2030 (USD Billion)
5.3 Ophthalmology
5.3.1 Ophthalmology Market, 2018 - 2030 (USD Billion)
5.3.2 Synthetic Corneas
5.3.2.1 Synthetic Corneas Market, 2018 - 2030 (USD Billion)
5.3.3 Intraocular Lens
5.3.3.1 Intraocular Lens Market, 2018 - 2030 (USD Billion)
5.3.4 Contact Lens
5.3.4.1 Contact Lens Market, 2018 - 2030 (USD Billion)
5.3.5 Ocular Tissue Replacement
5.3.5.1 Ocular Tissue Replacement Market, 2018 - 2030 (USD Billion)
5.3.6 Others
5.3.6.1 Other Ophthalmology Applications Market, 2018 - 2030 (USD Billion)
5.4 Dental
5.4.1 Dental Market, 2018 - 2030 (USD Billion)
5.4.2 Tissue Regeneration Materials
5.4.2.1 Tissue Regeneration Materials Market, 2018 - 2030 (USD Billion)
5.4.3 Dental Implants
5.4.3.1 Dental Implants Market, 2018 - 2030 (USD Billion)
5.4.4 Bone Grafts & Substitutes
5.4.4.1 Bone Grafts And Substitutes Market, 2018 - 2030 (USD Billion)
5.4.5 Dental Membranes
5.4.5.1 Dental Membranes Market, 2018 - 2030 (USD Billion)
5.4.6 Others
5.4.6.1 Other Dental Applications Market, 2018 - 2030 (USD Billion)
5.5 Orthopedic
5.5.1 Orthopedic Market, 2018 - 2030 (USD Billion)
5.5.2 Joint Replacement Biomaterials
5.5.2.1 Joint Replacement Biomaterials Market, 2018 - 2030 (USD Billion)
5.5.3 Orthobiologics
5.5.3.1 Orthobiologics Market, 2018 - 2030 (USD Billion)
5.5.4 Bio-Resorbable Tissue Fixation Products
5.5.4.1 Bio-Resorbable Tissue Fixation Products Market, 2018 - 2030 (USD Billion)
5.5.5 Viscosupplementation
5.5.5.1 Viscosupplementation Market, 2018 - 2030 (USD Billion)
5.5.6 Spine Biomaterials
5.5.6.1 Spine Biomaterials Market, 2018 - 2030 (USD Billion)
5.5.7 Others
5.5.7.1 Other Orthopedic Applications Market, 2018 - 2030 (USD Billion)
5.6 Wound Healing
5.6.1 Wound Healing Market, 2018 - 2030 (USD Billion)
5.6.2 Fracture Healing Device
5.6.2.1 Fracture Healing Device Market, 2018 - 2030 (USD Billion)
5.6.3 Adhesion Barrier
5.6.3.1 Adhesion Barrier Market, 2018 - 2030 (USD Billion)
5.6.4 Skin Substitutes
5.6.4.1 Skin Substitutes Market, 2018 - 2030 (USD Billion)
5.6.5 Internal Tissue Sealant
5.6.5.1 Internal Tissue Sealant Market, 2018 - 2030 (USD Billion)
5.6.6 Surgical Hemostats
5.6.6.1 Surgical Hemostats Market, 2018 - 2030 (USD Billion)
5.6.7 Others
5.6.7.1 Other Wound Healing Applications Market, 2018 - 2030 (USD Billion)
5.7 Tissue Engineering
5.7.1 Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.8 Plastic Surgery
5.8.1 Plastic Surgery Market, 2018 - 2030 (USD Billion)
5.8.2 Facial Wrinkle Treatment
5.8.2.1 Facial Wrinkle Treatment Market, 2018 - 2030 (USD Billion)
5.8.3 Soft Tissue Fillers
5.8.3.1 Soft Tissue Fillers Market, 2018 - 2030 (USD Billion)
5.8.4 Craniofacial Surgery
5.8.4.1 Craniofacial Surgery Market, 2018 - 2030 (USD Billion)
5.8.5 Bioengineered Skins
5.8.5.1 Bioengineered Skins Market, 2018 - 2030 (USD Billion)
5.8.6 Peripheral Nerve Repair
5.8.6.1 Peripheral Nerve Repair Market, 2018 - 2030 (USD Billion)
5.8.7 Acellular Dermal Matrices
5.8.7.1 Acellular Dermal Matrices Market, 2018 - 2030 (USD Billion)
5.8.8 Others
5.8.8.1 Other Plastic Surgery Applications Market, 2018 - 2030 (USD Billion)
5.9 Neurology
5.9.1 Neurology Market, 2018 - 2030 (USD Billion)
5.9.2 Neural Stem Cell Encapsulation
5.9.2.1 Neural Stem Cell Encapsulation Market, 2018 - 2030 (USD Billion)
5.9.3 Shunting Systems
5.9.3.1 Shunting Systems Market, 2018 - 2030 (USD Billion)
5.9.4 Hydrogel Scaffold
5.9.4.1 Hydrogel Scaffold Market, 2018 - 2030 (USD Billion)
5.9.5 Cortical Neural Prosthetics
5.9.5.1 Cortical Neural Prosthetics Market, 2018 - 2030 (USD Billion)
5.9.6 Others
5.9.6.1 Other Neurology Applications Market, 2018 - 2030 (USD Billion)
5.10 Others
5.10.1 Market For Other Applications Of Biomaterials, 2018 - 2030 (USD Billion)
Chapter 6 Biomaterials Market: Regional Business Analysis
6.1. Biomaterials Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Biomaterials Market, 2018 - 2030 (USD Billion)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Biomaterials Market, 2018 - 2030 (USD Billion)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Biomaterials Market, 2018 - 2030 (USD Billion)
6.3. Europe
6.3.1. SWOT Analysis
6.3.2. Europe Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. UK Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.4. Germany
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Germany Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. France Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Italy Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Spain Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Denmark Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Sweden Biomaterials Market, 2018 - 2030 (USD Billion)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Target Disease Prevalence
6.3.10.3. Competitive Scenario
6.3.10.4. Regulatory Framework
6.3.10.5. Norway Biomaterials Market, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. SWOT Analysis
6.4.2. Asia Pacific Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Japan Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. China Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. India Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Australia Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Thailand Biomaterials Market, 2018 - 2030 (USD Billion)
6.4.8. South Korea
6.4.8.1. Key Country Dynamics
6.4.8.2. Target Disease Prevalence
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.8.5. South Korea Biomaterials Market, 2018 - 2030 (USD Billion)
6.5. Latin America
6.5.1. SWOT Analysis
6.5.2. Latin America Biomaterials Market, 2018 - 2030 (USD Billion)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Brazil Biomaterials Market, 2018 - 2030 (USD Billion)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Mexico Biomaterials Market, 2018 - 2030 (USD Billion)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.5.5. Argentina Biomaterials Market, 2018 - 2030 (USD Billion)
6.6. MEA
6.6.1. SWOT Analysis
6.6.2. MEA Biomaterials Market, 2018 - 2030 (USD Billion)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. South Africa Biomaterials Market, 2018 - 2030 (USD Billion)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Saudi Arabia Biomaterials Market, 2018 - 2030 (USD Billion)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. UAE Biomaterials Market, 2018 - 2030 (USD Billion)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Competitive Scenario
6.6.6.4. Regulatory Framework
6.6.6.5. Kuwait Biomaterials Market, 2018 - 2030 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Company Categorization
7.2 Strategy Mapping
7.3 Company Market Share Analysis, 2022
7.4 Company Profiles/Listing
7.4.1 Medtronic
7.4.1.1 Overview
7.4.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3 Product Benchmarking
7.4.1.4 Strategic Initiatives
7.4.2 Evonik Industries AG
7.4.2.1 Overview
7.4.2.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3 Product Benchmarking
7.4.2.4 Strategic Initiatives
7.4.3 Carpenter Technology Corporation
7.4.3.1 Overview
7.4.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3 Product Benchmarking
7.4.3.4 Strategic Initiatives
7.4.4 Berkeley Advanced Biomaterials
7.4.4.1 Overview
7.4.4.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3 Product Benchmarking
7.4.4.4 Strategic Initiatives
7.4.5 Invibio Ltd.
7.4.5.1 Overview
7.4.5.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.5.3 Product Benchmarking
7.4.5.4 Strategic Initiatives
7.4.6 Zimmer Biomet Holdings, Inc.
7.4.6.1 Overview
7.4.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.6.3 Product Benchmarking
7.4.6.4 Strategic Initiatives
7.4.7 BASF SE
7.4.7.1 Overview
7.4.7.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.7.3 Product Benchmarking
7.4.7.4 Strategic Initiatives
7.4.8 Covalon Technologies Ltd.
7.4.8.1 Company Overview
7.4.8.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.8.3 Product Benchmarking
7.4.8.4 Strategic Initiatives
7.4.9 Stryker
7.4.9.1 Overview
7.4.9.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.9.3 Product Benchmarking
7.4.9.4 Strategic Initiatives
7.4.10 Johnson & Johnson
7.4.10.1 Overview
7.4.10.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.10.3 Product Benchmarking
7.4.10.4 Strategic Initiatives
7.4.11 Dentsply Sirona
7.4.11.1 Overview
7.4.11.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.11.3 Product Benchmarking
7.4.11.4 Strategic Initiatives
7.4.12 CoorsTek Inc.
7.4.12.1 Overview
7.4.12.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.12.3 Product Benchmarking
7.4.12.4 Strategic Initiatives
7.4.13 Corbion
7.4.13.1 Overview
7.4.13.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.13.3 Product Benchmarking
7.4.13.4 Strategic Initiatives
7.4.14 Collagen Matrix, Inc.
7.4.14.1 Overview
7.4.14.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.14.3 Product Benchmarking
7.4.14.4 Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 3 Global biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 4 Global biomaterials market, by region, 2018 - 2030 (USD Billion)
Table 5 North America biomaterials market, by country, 2018 - 2030 (USD Billion)
Table 6 North America biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 7 North America biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 8 U.S. biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 9 U.S. biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 10 Canada biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 11 Canada biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 12 Europe biomaterials market, by country, 2018 - 2030 (USD Billion)
Table 13 Europe biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 14 Europe biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 15 UK biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 16 UK biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 17 Germany biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 18 Germany biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 19 France biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 20 France biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 21 Italy biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 22 Italy biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 23 Spain biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 24 Spain biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 25 Denmark biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 26 Denmark biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 27 Sweden biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 28 Sweden biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 29 Norway biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 30 Norway biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 31 Asia Pacific biomaterials market, by country, 2018 - 2030 (USD Billion)
Table 32 Asia Pacific biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 33 Asia Pacific biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 34 Japan biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 35 Japan biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 36 China biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 37 China biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 38 India biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 39 India biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 40 Australia biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 41 Australia biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 42 Thailand biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 43 Thailand biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 44 South Korea biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 45 South Korea biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 46 Latin America biomaterials market, by country, 2018 - 2030 (USD Billion)
Table 47 Latin America biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 48 Latin America biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 49 Brazil biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 50 Brazil biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 51 Mexico biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 52 Mexico biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 53 Argentina biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 54 Argentina biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 55 Middle East & Africa biomaterials market, by country, 2018 - 2030 (USD Billion)
Table 56 Middle East & Africa biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 57 Middle East & Africa biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 58 South Africa biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 59 South Africa biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 60 Saudi Arabia biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 61 Saudi Arabia biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 62 UAE biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 63 UAE biomaterials market, by application, 2018 - 2030 (USD Billion)
Table 64 Kuwait biomaterials market, by product, 2018 - 2030 (USD Billion)
Table 65 Kuwait biomaterials market, by application, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Biomaterials market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Biomaterials market: Product outlook key takeaways
Fig. 15 Biomaterials market: Product movement analysis
Fig. 16 Global biomaterials market for metallic biomaterials, 2018 - 2030 (USD Billion)
Fig. 17 Global biomaterials market for natural biomaterials, 2018 - 2030 (USD Billion)
Fig. 18 Global biomaterials market for ceramics biomaterials, 2018 - 2030 (USD Billion)
Fig. 19 Global biomaterials market for polymers biomaterials, 2018 - 2030 (USD Billion)
Fig. 20 Biomaterial market: Application outlook & key takeaways
Fig. 21 Biomaterials market: Application movement analysis
Fig. 22 Global biomaterials market for cardiovascular, 2018 - 2030 (USD Billion)
Fig. 23 Global biomaterials market for sensors, 2018 - 2030 (USD Billion)
Fig. 24 Global biomaterials market for stents, 2018 - 2030 (USD Billion)
Fig. 25 Global biomaterials market for guidewires, 2018 - 2030 (USD Billion)
Fig. 26 Global biomaterials market for implantable cardiac defibrillators, 2018 - 2030 (USD Billion)
Fig. 27 Global biomaterials market for pacemakers, 2018 - 2030 (USD Billion)
Fig. 28 Global biomaterials market for vascular grafts, 2018 - 2030 (USD Billion)
Fig. 29 Global biomaterials market for other cardiovascular applications, 2018 - 2030 (USD Billion)
Fig. 30 Global biomaterials market for ophthalmology, 2018 - 2030 (USD Billion)
Fig. 31 Global biomaterials market for synthetic corneas, 2018 - 2030 (USD Billion)
Fig. 32 Global biomaterials market for intraocular lens, 2018 - 2030 (USD Billion)
Fig. 33 Global biomaterials market for contact lens, 2018 - 2030 (USD Billion)
Fig. 34 Global biomaterials market for ocular tissue replacement, 2018 - 2030 (USD Billion)
Fig. 35 Global biomaterials market for other opthalmology applications, 2018 - 2030 (USD Billion)
Fig. 36 Global biomaterials market for dental, 2018 - 2030 (USD Billion)
Fig. 37 Global biomaterials market for tissue regeneration materials, 2018 - 2030 (USD Billion)
Fig. 38 Global biomaterials market for dental implants, 2018 - 2030 (USD Billion)
Fig. 39 Global biomaterials market for bone grafts and substitutes, 2018 - 2030 (USD Billion)
Fig. 40 Global biomaterials market for dental membranes, 2018 - 2030 (USD Billion)
Fig. 41 Global biomaterials market for other dental applications, 2018 - 2030 (USD Billion)
Fig. 42 Global biomaterials market for orthopedic, 2018 - 2030 (USD Billion)
Fig. 43 Global biomaterials market for joint replacement biomaterials, 2018 - 2030 (USD Billion)
Fig. 44 Global biomaterials market for orthobiologics, 2018 - 2030 (USD Billion)
Fig. 45 Global biomaterials market for bio-resorbable tissue fixation products, 2018 - 2030 (USD Billion)
Fig. 46 Global biomaterials market for viscosupplementation, 2018 - 2030 (USD Billion)
Fig. 47 Global biomaterials market for spine biomaterials, 2018 - 2030 (USD Billion)
Fig. 48 Global biomaterials market for other orthopedic applications, 2018 - 2030 (USD Billion)
Fig. 49 Global biomaterials market for wound healing, 2018 - 2030 (USD Billion)
Fig. 50 Global biomaterials market for fracture healing device, 2018 - 2030 (USD Billion)
Fig. 51 Global biomaterials market for adhesion barrier, 2018 - 2030 (USD Billion)
Fig. 52 Global biomaterials market for skin substitutes, 2018 - 2030 (USD Billion)
Fig. 53 Global biomaterials market for internal tissue sealant, 2018 - 2030 (USD Billion)
Fig. 54 Global biomaterials market for surgical hemostats, 2018 - 2030 (USD Billion)
Fig. 55 Global biomaterials market for other wound healing applications, 2018 - 2030 (USD Billion)
Fig. 56 Global biomaterials market for tissue engineering, 2018 - 2030 (USD Billion)
Fig. 57 Global biomaterials market for plastic surgery, 2018 - 2030 (USD Billion)
Fig. 58 Global biomaterials market for facial wrinkle treatment, 2018 - 2030 (USD Billion)
Fig. 59 Global biomaterials market for soft tissue fillers, 2018 - 2030 (USD Billion)
Fig. 60 Global biomaterials market for craniofacial surgery, 2018 - 2030 (USD Billion)
Fig. 61 Global biomaterials market for bioengineered skins, 2018 - 2030 (USD Billion)
Fig. 62 Global biomaterials market for peripheral nerve repair, 2018 - 2030 (USD Billion)
Fig. 63 Global biomaterials market for acellular dermal matrices, 2018 - 2030 (USD Billion)
Fig. 64 Global biomaterials market for other plastic surgery applications, 2018 - 2030 (USD Billion)
Fig. 65 Global biomaterials market for neurology, 2018 - 2030 (USD Billion)
Fig. 66 Global biomaterials market for neural stem cell encapsulation, 2018 - 2030 (USD Billion)
Fig. 67 Global biomaterials market for shunting systems, 2018 - 2030 (USD Billion)
Fig. 68 Global biomaterials market for hydrogel scaffold, 2018 - 2030 (USD Billion)
Fig. 69 Global biomaterials market for cortical neural prosthetics, 2018 - 2030 (USD Billion)
Fig. 70 Global biomaterials market for other neurology applications, 2018 - 2030 (USD Billion)
Fig. 71 Global biomaterials market for other biomaterial applications, 2018 - 2030 (USD Billion)
Fig. 72 Regional market place: key takeaway
Fig. 73 Biomaterials market: Regional outlook, 2022 & 2030
Fig. 74 North America biomaterials market, 2018 - 2030 (USD Billion)
Fig. 75 U.S. biomaterials market, 2018 - 2030 (USD Billion)
Fig. 76 Canada biomaterials market, 2018 - 2030 (USD Billion)
Fig. 77 Europe biomaterials market, 2018 - 2030 (USD Billion)
Fig. 78 Germany biomaterials market, 2018 - 2030 (USD Billion)
Fig. 79 UK biomaterials market, 2018 - 2030 (USD Billion)
Fig. 80 France biomaterials market, 2018 - 2030 (USD Billion)
Fig. 81 Italy biomaterials market, 2018 - 2030 (USD Billion)
Fig. 82 Spain biomaterials market, 2018 - 2030 (USD Billion)
Fig. 83 Denmark biomaterials market, 2018 - 2030 (USD Billion)
Fig. 84 Sweden biomaterials market, 2018 - 2030 (USD Billion)
Fig. 85 Norway biomaterials market, 2018 - 2030 (USD Billion)
Fig. 86 Asia Pacific biomaterials market, 2018 - 2030 (USD Billion)
Fig. 87 Japan biomaterials market, 2018 - 2030 (USD Billion)
Fig. 88 China biomaterials market, 2018 - 2030 (USD Billion)
Fig. 89 India biomaterials market, 2018 - 2030 (USD Billion)
Fig. 90 South Korea biomaterials market, 2018 - 2030 (USD Billion)
Fig. 91 Thailand biomaterials market, 2018 - 2030 (USD Billion)
Fig. 92 Australia biomaterials market, 2018 - 2030 (USD Billion)
Fig. 93 Latin America biomaterials market, 2018 - 2030 (USD Billion)
Fig. 94 Brazil biomaterials market, 2018 - 2030 (USD Billion)
Fig. 95 Mexico biomaterials market, 2018 - 2030 (USD Billion)
Fig. 96 Argentina biomaterials market, 2018 - 2030 (USD Billion)
Fig. 97 Middle East Africa biomaterials market, 2018 - 2030 (USD Billion)
Fig. 98 South Africa biomaterials market, 2018 - 2030 (USD Billion)
Fig. 99 Saudi Arabia biomaterials market, 2018 - 2030 (USD Billion)
Fig. 100 UAE biomaterials market, 2018 - 2030 (USD Billion)
Fig. 101 Kuwait biomaterials market, 2018 - 2030 (USD Billion)

Companies Mentioned

  • Medtronic
  • Evonik Industries AG
  • Carpenter Technology Corporation
  • Berkeley Advanced Biomaterials
  • Invibio Ltd.
  • Zimmer Biomet Holdings, Inc.
  • BASF SE
  • Covalon Technologies Ltd.
  • Stryker
  • Johnson & Johnson
  • Dentsply Sirona
  • CoorsTek Inc.
  • Corbion
  • Collagen Matrix, Inc.

Methodology

Loading
LOADING...